4 recruiting, 2 terminated, 1 not yet recruiting, 1 unknown. 4 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Recruiting 3, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Bone Pain: new trials by email Literature Review of Bone Pain trials Research Report on Bone Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSF Breast Cancer, Chemotherapy-Induced Neutropenia | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 132 | 2026-09-30 | 2026-09-08 | |
| Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone Radiofrequency ablation and bone augmentation with radiotherapy, Radiotherapy alone - Spine Metastases, Bone Pain | Not applicable | Recruiting | University of Minnesota | 36 | 2025-12-01 | 2025-12-03 |
| Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain 153Sm-DOTMP - Bone Pain, Metastatic Bone Tumor | Phase 1 | Recruiting | Telix Pharmaceuticals (Innovations) Pty Limited | 33 | 2025-10-21 | 2026-05-14 |
| Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers Loratadine, Diosmin-Hesperidin, Loratadine + Diosmin-Hesperidin - Hematologic Malignancy, Neutropenia | Not applicable | Recruiting | Alexandria University | 88 | 2025-03-01 | 2026-06-24 |
| Correlation of Timing of Pegfilgrastim Administration and PIBP. Timing of pegfilgrastim administration - Pegfilgrastim, Bone Pain | Not applicable | Unknown | Guangdong Provincial People's Hospital | 156 | 2023-05-04 | 2024-09-19 |
| Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use Loratadine, Placebo - Bone Pain | Phase 2 | Terminated | University of Michigan | 3 | 2019-06-24 | 2020-10-22 |
| Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma Quality-of-Life Assessment, Questionnaire Administration, Radiation Therapy - Bone Pain, Metastatic Malignant Neoplasm in the Bone | Not applicable | Recruiting | University of Southern California | 100 | 2019-03-11 | 2026-06-05 |
| Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone Biospecimen Collection, Laboratory Biomarker Analysis, Quality-of-Life Assessment - Bone Pain, Breast Carcinoma Metastatic in the Bone | Terminated | Wake Forest University Health Sciences | 17 | 2019-01-31 | 2026-08-03 |
Breast Neoplasms (2) · Bone Neoplasms (1) · Febrile Neutropenia (1) · Hematologic Neoplasms (1) · Multiple Myeloma (1) · Neutropenia (1)
Neoplasms (5) · Neoplasms by Site (4) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Agranulocytosis (2) · Breast Diseases (2) · Cytopenia (2) · Leukocyte Disorders (2) · Leukopenia (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Blood Protein Disorders (1) · Bone Diseases (1) · Cardiovascular Diseases (1) · Hemorrhagic Disorders (1)
Loratadine (2) · Radiotherapy (2) · Radiation (1) · Radiofrequency Ablation (1)
Alexandria University (1) · Guangdong Provincial People's Hospital (1) · Telix Pharmaceuticals (Innovations) Pty Limited (1) · The First Affiliated Hospital with Nanjing Medical University (1) · University of Michigan (1) · University of Minnesota (1) · University of Southern California (1) · Wake Forest University Health Sciences (1)
United States (5) · China (1) · Egypt (1)
Adam Garsa, MD (1) · Doris Brown (1) · Kelly Walkovich (1) · Kun Wang, professor (1) · Mai Moustafa Helmy, Professor (1) · Mayssaa Mohamed Elsayed, pharmD (1) · Noha Alaa Eldin Hamdy, Assistant professor (1) · Omar Mohamed Ghallab, Professor (1) · Reham AbdelHalem Abo Elwafa, Professor (1) · Reza Talaie (1)
P30CA012197 (1), P30CA014089 (1)